Baird Medical seems to be overvalued based on Macroaxis valuation methodology. Our model approximates the value of Baird Medical Investment from analyzing the firm technical indicators and probability of bankruptcy. In general, investors favor buying undervalued stocks and disposing overvalued stocks since, at some point, stock prices and their ongoing real values will blend.
Overvalued
Today 0.14
Please note that Baird Medical's price fluctuation is out of control at this time. Calculation of the real value of Baird Medical Investment is based on 3 months time horizon. Increasing Baird Medical's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Baird stock is determined by what a typical buyer is willing to pay for full or partial control of Baird Medical Investment. Since Baird Medical is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Baird Stock. However, Baird Medical's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value.
Historical
Market 0.14
Real 0.11
Hype 0.14
Naive 0.0973
The intrinsic value of Baird Medical's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Baird Medical's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Baird Medical Investment helps investors to forecast how Baird stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Baird Medical more accurately as focusing exclusively on Baird Medical's fundamentals will not take into account other important factors:
Baird Medical Investment is currently forecasted to have takeover price of 0 with market capitalization of 0, debt of , and cash on hands of . Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Baird Medical fundamentals before making investing decisions based on enterprise value of the company
The concept of asset utilization usually refers to the revenue earned for every dollar of assets a company currently reports. The latest return on assets of Baird indicates not a very effective usage of assets in January.
About Baird Medical Valuation
Our relative valuation model uses a comparative analysis of Baird Medical. We calculate exposure to Baird Medical's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Baird Medical's related companies.
When running Baird Medical's price analysis, check to measure Baird Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Baird Medical is operating at the current time. Most of Baird Medical's value examination focuses on studying past and present price action to predict the probability of Baird Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Baird Medical's price. Additionally, you may evaluate how the addition of Baird Medical to your portfolios can decrease your overall portfolio volatility.